Healthcare

passed · New York · Senate Mar 4, 2026

S 8334: Relates to insurance reimbursement for vaccination for severe acute respiratory syndrome coronavirus 2

S 8334 requires health insurance plans to cover all recommended doses of the COVID-19 vaccine (SARS-CoV-2), adding it to a list of mandatory immunizations already covered by New York insurance law. This affects insurance companies, healthcare providers, and patients by mandating reimbursement for the vaccine without cost-sharing. The bill amends multiple sections of New York’s insurance and social services laws to include "severe acute respiratory syndrome coronavirus 2" in required coverage, aligning with federal standards for biological products. It applies to all insurance contracts effective January 1 after the law takes effect.

Topics ✓ HealthcareSupports HealthcareMandates insurance coverage for COVID-19 vaccine without cost-sharing, expanding patient access to essential healthcare services.95% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

Track

passed · New York · Senate Feb 24, 2026

S 1618: Enacts the "New York affordable drug manufacturing act"

Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.

Topics ✓ HealthcareSupports HealthcareBill mandates partnerships to lower drug prices, reduce costs for consumers, and increase patient access to affordable medications - directly advancing healthcare affordability.95% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

Track

passed · New York · Senate Feb 24, 2026

S 3203: Preserves access to affordable drugs

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Topics ✓ HealthcareSupports HealthcareBill preserves drug affordability by presuming anticompetitive patent settlements that limit generic drug access, directly advancing patient access to affordable medications per healthcare topic definition.95% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

Track

passed · New York · Senate Feb 11, 2026

S 317: Requires anti-bias training for every medical student, medical resident and physician assistant student in the state

Requires anti-bias training for every medical student, medical resident and physician assistant student in the state; requires the department of health to make an annual report on the implementation and effectiveness of such training.

Topics ✓ EducationSupports EducationMandates anti-bias training for medical students in higher education, enhancing curriculum standards within educational institutions.90% confidence ✓ HealthcareSupports HealthcareRequires anti-bias training for medical students/residents to improve equitable care delivery, aligning with patient access and rights protections in healthcare policy.85% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

Track

signed · New York · Assembly Feb 6, 2026

A 9515: Relates to requirements for the provision of medication for medical aid in dying

Relates to requirements for medical professionals and health care facilities that provide medication to patients for medical aid in dying; extends the initial effectiveness of certain provisions relating thereto.

Topics ✓ HealthcareSupports HealthcareRegulates medical aid in dying protocols, enabling patient access to end-of-life care within healthcare system per bill's focus on provider requirements.90% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

signed · New York · Assembly Feb 6, 2026

A 136: Relates to the medical aid in dying act

This bill establishes New York's "Medical Aid in Dying Act," allowing terminally ill adults (18+) with decision-making capacity to request and self-administer medication to end their life. To qualify, a patient must have a terminal illness confirmed by two physicians (the attending physician and a consulting physician) and make an informed decision after being fully informed of alternatives, risks, and outcomes. The process requires an oral request, a written request signed by the patient and witnessed by two non-conflicted adults (not relatives or beneficiaries), and includes the right to rescind the request at any time. The bill also mandates documentation, safe disposal of unused medication, and state reporting.

Topics ✓ HealthcareSupports HealthcareBill establishes patient rights in end-of-life care, allowing terminally ill adults to request medication for a peaceful death under physician supervision, aligning with healthcare patient rights protection.90% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

died · New York · Senate Jan 29, 2026

S 1683: Enacts the "public university emergency contraception education act"

Enacts the "public university emergency contraception education act" requiring public universities to develop, produce and distribute informational materials related to emergency contraception.

Topics ✓ EducationSupports EducationBill mandates public universities to distribute emergency contraception educational materials, expanding access to health education resources under higher education, directly supporting educational access.95% confidence ✓ HealthcareSupports HealthcareRequires public universities to distribute emergency contraception education materials, improving access to reproductive health information and services.95% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

Track

passed both · New York · Senate Jan 28, 2026

S 8544: Excludes certain medication abortion drugs from being deemed unlawful to prescribe or dispense and from being deemed misbranded under certain circumstances

Provides that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion shall not be considered a criminal conversion act under certain circumstances; provides that mifepristone or any drug used for medication abortion shall not be deemed to be adulterated or misbranded under certain circumstances.

Topics ✓ HealthcareSupports HealthcareBill removes legal barriers to prescribing medication abortion drugs, enhancing patient access to reproductive healthcare services.95% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

Track

passed · New York · Senate Jan 27, 2026

S 8866: Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility

Establishes "The Equity in Fertility Treatment Act"; relates to the definition of infertility and health insurance coverage for the treatment of infertility.

Topics ✓ HealthcareSupports HealthcareBill mandates health insurance coverage for infertility treatment, expanding patient access to reproductive healthcare services per its title and summary.95% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

Track

passed · New York · Senate Jan 27, 2026

S 8656: Relates to the dispensing of certain prescriptions

Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.

Topics ✓ HealthcareSupports HealthcareBill removes patient/dispenser info requirement on prescriptions for mifepristone/misoprostol, enhancing privacy and access to reproductive healthcare services.90% confidence | Rep's Stance ✗ Voted No ✗ Opposes Healthcare

Track